Status:
RECRUITING
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
Lead Sponsor:
Hunan Cancer Hospital
Conditions:
Breast Neoplasms
Neoplastic Cells, Circulating
Eligibility:
FEMALE
18-75 years
Brief Summary
The phenotype of circulating tumor cells (CTCs) is supposed to be significant indicator that is correlated the prognosis of breast cancer patients who have completed neoadjuvant chemotherapy, primary ...
Detailed Description
The aim of this observational study is to assess the efficacy of CTCs surveillance in predicting the treatment response of neoadjuvant chemotherapy, surgery and adjuvant chemotherapy. This study also ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- The age is more than 18 years old;
- Pathology confirmed malignant breast tumor;
- No clinical diagnosis of other malignancies, unstable complications or uncontrolled infection;
- Life expectancy is greater than 6 month;
- The main organ function is normal;
- The subjects volunteered to participate in this study, signed informed consent, followed up with good compliance.
- Exclusion Criteria
- Patients who had suffered from other malignant tumors;
- With uncontrolled bacterial, viral or fungal infections;
- With physical or mental disorders
- Without or limited civil capacity;
- Infected with human immunodeficiency virus (HIV)；
- Circumstances in which the investigator considers it inappropriate to participate in this study.
Exclusion
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2029
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05326295
Start Date
March 1 2019
End Date
March 1 2029
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hunan Cancer Hospital
Changsha, Hunan, China, 410006